Keywords

angiotensin II acetate, baricitinib, bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate, Biktarvy, elagolix sodium, ibalizumab-uiyk, lofexidine hydrochloride, sodium zirconium cyclosilicate, tildrakizumab-asmn

Authors

1. Hussar, Daniel A. PhD

Abstract

Abstract: This article reviews eight drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.